Hemant Surgical Industries Ltd

Hemant Surgical Industries Ltd

₹ 133 9.14%
28 Mar - close price
About

Incorporated in 1989, Hemant Surgical Industries Ltd is in the business of Medical Equipment & Supplies[1]

Key Points

Business Overview:[1][2]
HSIL is ISO 9001:2015, ISO 13485:2016 certified and CDSCO compliant company which deals in importing, manufacturing, and marketing medical disposable, surgical equipments and pharmaceutical products including
a) Supply of dialysis equipment, renal care, oxygen concentrators, air mattresses, ultrasound machines and digital thermometers, etc.
b) Design and manufacture of a range of nebulisers, which are
marketed under the company’s AERO brand
c) HSIL also refurbishes second-hand dialysis machines, manufactures
and supplies related accessories, dialysers and haemodialysis solutions

  • Market Cap 139 Cr.
  • Current Price 133
  • High / Low 260 / 121
  • Stock P/E 18.1
  • Book Value 46.8
  • Dividend Yield 0.00 %
  • ROCE 45.0 %
  • ROE 41.7 %
  • Face Value 10.0

Pros

  • Company has reduced debt.
  • Company has delivered good profit growth of 52.2% CAGR over last 5 years
  • Company has a good return on equity (ROE) track record: 3 Years ROE 35.0%
  • Company's working capital requirements have reduced from 27.4 days to 14.7 days

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend
  • Debtor days have increased from 46.7 to 57.6 days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Healthcare Industry: Healthcare

Loading peers table ...

Half Yearly Results

Figures in Rs. Crores

Sep 2022 Sep 2023
51 48
47 44
Operating Profit 4 3
OPM % 8% 7%
1 3
Interest 1 1
Depreciation 0 1
Profit before tax 4 5
Tax % 36% 17%
2 4
EPS in Rs 124.73 3.75
Raw PDF

Profit & Loss

Figures in Rs. Crores

Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
51 56 56 60 101 109
48 53 53 57 95 98
Operating Profit 2 3 3 3 6 11
OPM % 5% 5% 5% 5% 6% 10%
0 0 0 1 2 2
Interest 1 1 2 2 2 2
Depreciation 0 1 0 1 1 1
Profit before tax 1 1 1 1 6 10
Tax % 10% 8% 41% 9% 25% 24%
1 1 0 1 5 8
EPS in Rs 50.76 61.02 27.00 73.43 248.92 413.07
Dividend Payout % 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: %
5 Years: 17%
3 Years: 25%
TTM: 8%
Compounded Profit Growth
10 Years: %
5 Years: 52%
3 Years: 148%
TTM: 66%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: %
Return on Equity
10 Years: %
5 Years: 29%
3 Years: 35%
Last Year: 42%

Balance Sheet

Figures in Rs. Crores

Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Sep 2023
Equity Capital 2 2 2 2 2 8 10
Reserves 5 6 5 8 11 16 38
9 11 14 14 10 7 7
12 14 23 15 32 34 34
Total Liabilities 28 33 44 40 54 65 90
7 8 10 11 12 13 17
CWIP 0 0 0 0 0 0 0
Investments 0 0 1 0 1 0 0
21 25 33 29 42 51 73
Total Assets 28 33 44 40 54 65 90

Cash Flows

Figures in Rs. Crores

Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
0 0 2 -4 12 9
0 0 -2 -2 -0 -2
0 0 2 5 -8 -4
Net Cash Flow 0 0 2 -2 4 3

Ratios

Figures in Rs. Crores

Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Debtor Days 35 36 35 26 56 58
Inventory Days 64 73 125 113 57 67
Days Payable 102 97 143 89 92 110
Cash Conversion Cycle -3 12 17 51 21 15
Working Capital Days 12 23 14 66 2 15
ROCE % 15% 12% 14% 32% 45%

Shareholding Pattern

Numbers in percentages

Sep 2023
73.56%
0.03%
4.26%
22.14%
No. of Shareholders 722

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents